China SXT Pharmaceuticals (SXTC) Enterprise Value: 2017-2025
Historic Enterprise Value for China SXT Pharmaceuticals (SXTC) over the last 9 years, with Mar 2025 value amounting to -$8.4 million.
- China SXT Pharmaceuticals' Enterprise Value rose 132.97% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.8 million, marking a year-over-year increase of 32.19%. This contributed to the annual value of -$8.4 million for FY2025, which is 13.61% up from last year.
- Per China SXT Pharmaceuticals' latest filing, its Enterprise Value stood at -$8.4 million for FY2025, which was up 13.61% from -$9.7 million recorded in FY2024.
- China SXT Pharmaceuticals' Enterprise Value's 5-year high stood at $15.2 million during FY2021, with a 5-year trough of -$15.0 million in FY2023.
- In the last 3 years, China SXT Pharmaceuticals' Enterprise Value had a median value of -$9.7 million in 2024 and averaged -$11.0 million.
- Its Enterprise Value has fluctuated over the past 5 years, first spiked by 179.30% in 2021, then plummeted by 171.82% in 2022.
- Over the past 5 years, China SXT Pharmaceuticals' Enterprise Value (Yearly) stood at $15.2 million in 2021, then tumbled by 171.82% to -$10.9 million in 2022, then slumped by 38.06% to -$15.0 million in 2023, then spiked by 35.46% to -$9.7 million in 2024, then increased by 13.61% to -$8.4 million in 2025.